Regenerex Pharma (RGPX) Total Current Liabilities (2010 - 2025)
Regenerex Pharma (RGPX) reported Total Current Liabilities of $4.9 million for Q3 2025, up 1.51% year-over-year from $4.9 million in Q3 2024, and up 1.47% on a QoQ basis from $4.9 million in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Total Current Liabilities data on file, last reported at $4.9 million in Q3 2025.
- Quarterly Total Current Liabilities rose 1.51% year-over-year to $4.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.9 million (up 1.51% YoY) and the FY2025 annual result came in at $4.9 million, up 28.11% from the prior year.
- Total Current Liabilities advanced to $4.9 million in Q3 2025 per RGPX's latest filing, from $4.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $5.2 million in Q4 2024 and bottomed at $598829.0 in Q4 2021.
- The 5-year median for Total Current Liabilities is $874874.0 (2022), against an average of $2.5 million.
- The widest annual swing landed in 2021, when Total Current Liabilities decreased 12.53%; it then surged 450.5% in 2024.
- Tracing RGPX's Total Current Liabilities over 5 years: stood at $598829.0 in 2021, then jumped by 46.1% to $874874.0 in 2022, then jumped by 306.88% to $3.6 million in 2023, then jumped by 44.96% to $5.2 million in 2024, then slipped by 4.58% to $4.9 million in 2025.
- Per Business Quant, the three latest RGPX Total Current Liabilities figures stand at $4.9 million (Q3 2025), $4.9 million (Q2 2025), and $4.9 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 4.92 Mn |
| Dec 31, 2024 | 5.16 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 3.34 Mn |
| Jun 30, 2023 | 801,726.00 |
| Mar 31, 2023 | 776,782.00 |
| Dec 31, 2022 | 874,874.00 |
| Sep 30, 2022 | 780,354.00 |
| Jun 30, 2022 | 746,932.00 |
| Mar 31, 2022 | 660,453.00 |
| Dec 31, 2021 | 598,829.00 |
| Sep 30, 2021 | 652,856.00 |
| Jun 30, 2021 | 626,084.00 |
| Mar 21, 2021 | 621,319.00 |
| Dec 31, 2020 | 684,600.00 |
| Sep 30, 2020 | 604,374.00 |
| Jun 30, 2020 | 593,804.00 |
| Mar 31, 2020 | 518,718.00 |
| Dec 31, 2019 | 490,176.00 |
| Sep 30, 2019 | 534,425.00 |
| Jun 30, 2019 | 409,374.00 |
| Mar 31, 2019 | 405,308.00 |
| Dec 31, 2018 | 394,634.00 |
| Sep 30, 2018 | 356,238.00 |
| Jun 30, 2018 | 352,820.00 |
| Mar 31, 2018 | 336,175.00 |
| Dec 31, 2017 | 335,779.00 |
| Jun 30, 2017 | 314,788.00 |
| Mar 31, 2017 | 281,685.00 |
| Aug 31, 2014 | 757,599.00 |
| Nov 30, 2013 | 1.75 Mn |
| Aug 31, 2013 | 1.50 Mn |
| May 31, 2013 | 1.27 Mn |
| Feb 28, 2013 | 1.05 Mn |
| Nov 30, 2012 | 815,097.00 |
| Aug 31, 2012 | 334,308.00 |
| May 31, 2012 | 328,171.00 |
| Feb 29, 2012 | 329,100.00 |
| Nov 30, 2011 | 199,123.00 |
| Aug 31, 2011 | 38,046.00 |
| Nov 30, 2010 | 29,133.00 |